Over the last two decades, South Africa made massive progress in reducing transmission of HIV from mothers to their babies. Even so, about 7 000 babies still contract the virus every year. Experts put this down to having the right puzzle pieces for prevention but failing to integrate them optimally. Elna Schütz reports.
The Special Tribunal has ordered four ambulance companies run by Thapelo Buthelezi to pay back a total of over half-a-billion rand. The matter relates to contracts awarded by the Free State government, which were first reported on in Spotlight’s #Health4Sale series of investigative articles in 2018.
Clinical trial participants appear to be well protected in South Africa, particularly as the country’s guidelines recognise the risks of research with international collaborators. The sudden end of US-funded clinical trials, however, is exposing some limitations of ethics codes and guidelines, argues Dr Andy Gray.
US funding for clinical research in South Africa is incrementally being cancelled. This is happening through at least two processes – the first is by banning certain kinds of foreign grants called sub-awards (which is affecting everyone globally). The second is by failing to issue routine renewals of grants for clinical studies in South Africa. Spotlight and GroundUp break down the current situation.
Trade unions, medical associations and universities are raising the alarm that Gauteng budget cuts at the cost of doctors’ take-home pay will have dire consequences for public sector health. Meanwhile, the National Minister of Health has convened a committee to review the future of overtime for state doctors. Ufrieda Ho reports.
Research led by Professor Adrie Bekker is paving the way for an important HIV medicine to be made available to neonates in a way that is both safe and much more convenient than previous options. Biénne Huisman met with the passionate clinician-scientist at her office in Cape Town.
Experts say bacterial infections are responsible for more infant deaths than is generally recognised, and things may get worse as more of the bugs become resistant to commonly used antibiotics. Sue Segar asked local experts about this growing threat to newborns.
It is widely acknowledged among health and demographic experts that relying solely on what is written on death certificates does not paint an accurate picture of what people in South Africa are actually dying of. Now, an SAMRC study has provided evidence that the undercounting of deaths due to HIV might be even greater than previously thought. Chris Bateman reports.
We’re watching the largest HIV treatment programme in the world unravelling in real time. We don’t need perfection, but we do need a combination of urgency, action, and strategy to save it, argues Professor Francois Venter.
In late-January, the US suspended billions of dollars worth of international aid, including for HIV-related programmes in South Africa. The South African government could have responded by triggering an emergency funding mechanism but has failed to do so yet. In the meantime, activists, health researchers and even technical advisors to government are growing increasingly frustrated with the government’s lack of transparency on this issue.
Health research in South Africa has been plunged into crisis with the abrupt termination of several large research grants from the US, with more grant terminations expected in the coming days and weeks. Professor Ntobeko Ntusi, head of the South African Medical Research Council, tells Spotlight about efforts to find alternative funding and to preserve the country’s health research capacity.
While likely years away from widespread use, a test for TB that relies on a simple tongue swab instead of a person having to cough up sputum is showing promise. Elri Voigt takes stock of how the test works and asks experts what its future role might be.
